Taysha Gene Therapies, Inc. (TSHA)
NASDAQ·Healthcare·Biotechnology
$5.73
+5.13%
Mkt Cap $1.77B
Analyst Ratings
Buy
10
Hold
0
Sell
0
Price Target (18 analysts)
$14.00
Range $13.00 – $15.00
Implied Upside
+144.3%
Consensus $14.00 vs current $5.73
NASDAQ·Healthcare·Biotechnology
$5.73
+5.13%
Mkt Cap $1.77B
Buy
10
Hold
0
Sell
0
Price Target (18 analysts)
$14.00
Range $13.00 – $15.00
+144.3%
Consensus $14.00 vs current $5.73